Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMPARE STEMI ONE
NCT05491200Phase 4Recruiting
- Sponsor
- Research Cardiologen Rotterdam Zuid
- Start
- Jul 2022
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 4 trial of prasugrel in ST-segment elevation myocardial infarction (STEMI), sponsored by Research Cardiologen Rotterdam Zuid. Started Jul 2022; status: recruiting.
02
Drugs
prasugrel
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT05491200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05491200.